Drug & medication recalls Moderate risk

Teva Pharmaceuticals USA recalls Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count…

Recall date
October 25, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0069-2018
FDA classification
Class II
Brand / firm
Teva Pharmaceuticals USA
Sold / distributed
Nationwide in the USA and Puerto Rico.

Why it was recalled

Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Dutasteride and Tamsulosin HCl Capsules, 0.5 mg/ 0.4 mg, packaged in a) 30-count bottle (NDC 0591-3771-30), b) 90-count bottle (NDC 0591-3771-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314 USA; Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA.

Get recall alerts

Free email alert whenever Teva Pharmaceuticals USA has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Teva Pharmaceuticals USA